NF-κB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4896-4903

  Benjamin, John T ^a,b   Carver, Billy J ^a,b   Plosa, Erin J ^a   Yamamoto, Yasutoshi ^a   Miller, J Davin ^a,b   Liu, Jin Hua ^a   Van Der Meer, Riet ^a   Blackwell, Timothy S ^a,c,d   Prince, Lawrence S ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Affairs Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FIBROBLAST GROWTH FACTOR 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR SP1; FGF10 PROTEIN, HUMAN; PROTEIN KINASE; SP1 KINASE;

AIRWAY; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; EXPLANT; FETUS; LUNG PARENCHYMA; MESENCHYME; MORPHOGENESIS; MOUSE; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRACHEA; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHORIOAMNIONITIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LUNG; METABOLISM; NEWBORN; PREGNANCY; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CHORIOAMNIONITIS; CHROMATIN IMMUNOPRECIPITATION; FEMALE; FIBROBLAST GROWTH FACTOR 10; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFANT, NEWBORN; LUNG; MICE; MICE, INBRED BALB C; NF-KAPPA B; PREGNANCY; PREMATURE BIRTH; PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 78049509166     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001857     Document Type: Article

References (40)

1. Warburton, D., M. Schwarz, D. Tefft, G. Flores-Delgado, K. D. Anderson, and W. V. Cardoso. 2000. The molecular basis of lung morphogenesis. Mech. Dev. 92:55-81.
2. Perl, A. K., and J. A. Whitsett. 1999. Molecular mechanisms controlling lung morphogenesis. Clin. Genet. 56:14-27.
3. Hogan, B. L., and J. M. Yingling. 1998. Epithelial/mesenchymal interactions and branching morphogenesis of the lung. Curr. Opin. Genet. Dev. 8:481-486.
4. Weaver, M., L. Batts, and B. L. Hogan. 2003. Tissue interactions pattern the mesenchyme of the embryonic mouse lung. Dev. Biol. 258:169-184.
5. Weaver, M., N. R. Dunn, and B. L. Hogan. 2000. Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis. Development 127:2695-2704.
6. Hokuto, I., A. K. Perl, and J. A. Whitsett. 2003. Prenatal, but not postnatal, inhibition of fibroblast growth factor receptor signaling causes emphysema. J. Biol. Chem. 278:415-421.
7. Christou, H., and D. Brodsky. 2005. Lung injury and bronchopulmonary dysplasia in newborn infants. J. Intensive Care Med. 20:76-87.
8. MacDorman, M. F., J. A. Martin, T. J. Matthews, D. L. Hoyert, and S. J. Ventura. 2005. Explaining the 2001-2002 infant mortality increase: data from the linked birth/infant death data set. Natl. Vital Stat. Rep. 53:1-22.
9. May, C., M. Prendergast, S. Salman, G. F. Rafferty, and A. Greenough. 2009. Chest radiograph thoracic areas and lung volumes in infants developing bronchopulmonary dysplasia. Pediatr. Pulmonol. 44:80-85.
10. Watterberg, K. L., L. M. Demers, S. M. Scott, and S. Murphy. 1996. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 97:210-215.
11. Klinger, G., I. Levy, L. Sirota, V. Boyko, L. Lerner-Geva, B. Reichman; in collaboration with the Israel Neonatal Network. 2010. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics 125: e736-e740.
12. Prince, L. S., H. I. Dieperink, V. O. Okoh, G. A. Fierro-Perez, and R. L. Lallone. 2005. Toll-like receptor signaling inhibits structural development of the distal fetal mouse lung. Dev. Dyn. 233:553-561.
13. Benjamin, J. T., R. J. Smith, B. A. Halloran, T. J. Day, D. R. Kelly, and L. S. Prince. 2007. FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L550-L558.
14. Dieperink, H. I., T. S. Blackwell, and L. S. Prince. 2006. Hyperoxia and apoptosis in developing mouse lung mesenchyme. Pediatr. Res. 59:185-190.
15. Prince, L. S., V. O. Okoh, T. O. Moninger, and S. Matalon. 2004. Lipopolysaccharide increases alveolar type II cell number in fetal mouse lungs through Toll-like receptor 4 and NF-kappaB. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L999-L1006.
16. Arocho, A., B. Chen, M. Ladanyi, and Q. Pan. 2006. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn. Mol. Pathol. 15:56-61.
17. Agarwal, P., J. N. Wylie, J. Galceran, O. Arkhitko, C. Li, C. Deng, R. Grosschedl, and B. G. Bruneau. 2003. Tbx5 is essential for forelimb bud initiation following patterning of the limb field in the mouse embryo. Development 130:623-633.
18. Cheng, D. S., W. Han, S. M. Chen, T. P. Sherrill, M. Chont, G. Y. Park, J. R. Sheller, V. V. Polosukhin, J. W. Christman, F. E. Yull, and T. S. Blackwell. 2007. Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J. Immunol. 178:6504-6513.
19. Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science (New York, N. Y) 234:47-52.
20. Wierstra, I. 2008. Sp1: emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem. Biophys. Res. Commun. 372:1-13.
21. Jobe, A. J. 1999. The new BPD: an arrest of lung development. Pediatr. Res. 46:641-643.
22. Klinger, G., I. Levy, L. Sirota, V. Boyko, B. Reichman, and L. Lerner-Geva. 2009. Epidemiology and risk factors for early onset sepsis among very-lowbirthweight infants. Am. J. Obstet. Gynecol. 201:38. e1-6.
23. Garland, S. M., F. Ní Chuileannáin, C. Satzke, and R. Robins-Browne. 2002. Mechanisms, organisms and markers of infection in pregnancy. J. Reprod. Immunol. 57:169-183.
24. Li, Q., and I. M. Verma. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:725-734.
25. Johnson, B. H., M. Yi, A. Masood, R. Belcastro, J. Li, S. Shek, C. Kantores, R. P. Jankov, and A. K. Tanswell. 2009. A critical role for the IL-1 receptor in lung injury induced in neonatal rats by 60% O2. Pediatr. Res. 66:260-265.
26. Ozato, K., H. Tsujimura, and T. Tamura. 2002. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques (Suppl): 66-68, 70, 72 passim.
27. Campbell, K. J., S. Rocha, and N. D. Perkins. 2004. Active repression of antiapoptotic gene expression by RelA (p65) NF-kappa B. Mol. Cell 13:853-865.
28. Sitcheran, R., P. C. Cogswell, and A. S. Baldwin, Jr. 2003. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev. 17:2368-2373.
29. Zhu, N. L., C. Li, H. H. Huang, M. Sebald, V. A. Londhe, N. Heisterkamp, D. Warburton, S. Bellusci, and P. Minoo. 2007. TNF-alpha represses transcription of human Bone Morphogenetic Protein-4 in lung epithelial cells. Gene 393:70-80.
30. Baugé, C., G. Beauchef, S. Leclercq, S. J. Kim, J. P. Pujol, P. Galéra, and K. Boumédiene. 2008. NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression. J. Cell. Mol. Med. 12 (5 A): 1754-1766.
31. Verrecchia, F., E. F. Wagner, and A. Mauviel. 2002. Distinct involvement of the Jun-N-terminal kinase and NF-kappaB pathways in the repression of the human COL1A2 gene by TNF-alpha. EMBO Rep. 3:1069-1074.
32. Chadjichristos, C., C. Ghayor, M. Kypriotou, G. Martin, E. Renard, L. Ala-Kokko, G. Suske, B. de Crombrugghe, J. P. Pujol, and P. Galéra. 2003. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes. J. Biol. Chem. 278:39762-39772.
33. Courey, A. J., D. A. Holtzman, S. P. Jackson, and R. Tjian. 1989. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59:827-836.
34. Perkins, N. D., A. B. Agranoff, E. Pascal, and G. J. Nabel. 1994. An interaction between the DNA-binding domains of RelA (p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol. Cell. Biol. 14:6570-6583.
35. Hirano, F., H. Tanaka, Y. Hirano, M. Hiramoto, H. Handa, I. Makino, and C. Scheidereit. 1998. Functional interference of Sp1 and NF-kappaB through the same DNA binding site. Mol. Cell. Biol. 18:1266-1274.
36. Liu, A., P. W. Hoffman, W. Lu, and G. Bai. 2004. NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation. J. Biol. Chem. 279:17449-17458.
37. Kang, S. H., D. A. Brown, I. Kitajima, X. Xu, O. Heidenreich, S. Gryaznov, and M. Nerenberg. 1996. Binding and functional effects of transcriptional factor Sp1 on the murine interleukin-6 promotor. J. Biol. Chem. 271:7330-7335.
38. Kuang, P. P., J. L. Berk, D. C. Rishikof, J. A. Foster, D. E. Humphries, D. A. Ricupero, and R. H. Goldstein. 2002. NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype. Am. J. Physiol. Cell Physiol. 283: C58-C65.
39. Majello, B., P. De Luca, and L. Lania. 1997. Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J. Biol. Chem. 272:4021-4026.
40. Yu, B., P. K. Datta, and S. Bagchi. 2003. Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res. 31:5368-5376.